Finding genetic causes of childhood developmental disorders in Africa

Advancing discovery for developmental disorders - expanded analysis of the DDD-Africa resource

NIH-funded research Wits Health Consortium (Pty), LTD · NIH-11394170

Researchers will use clinical information, DNA data, and computer-based tools to find genetic changes that help diagnose African children with developmental delays and intellectual disability.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWits Health Consortium (Pty), LTD NIH-funded
Lab location1 site (Parktown, South Africa)
Project IDNIH-11394170 on NIH RePORTER

What this research studies

If your child has unexplained developmental delays or intellectual disability, this project uses existing clinical records and DNA samples collected through DDD-Africa to look for genetic causes. Scientists will combine several DNA analysis methods to find structural gene changes, look for genome-wide DNA methylation patterns, and apply AI that links medical features with genetic findings. The team aims to increase the number of children who receive a clear genetic diagnosis and to make those diagnoses more accurate for African patients. Results could help families get better genetic counseling and guide medical care.

Who could benefit from this research

Good fit: Children in African settings with unexplained developmental delays or intellectual disability and families willing to share clinical information and DNA samples are the ideal participants.

Not a fit: People without developmental disorders or those whose condition already has a confirmed non-genetic cause are unlikely to benefit directly from this project.

Why it matters

Potential benefit: If successful, the work could increase the number of African children who receive a genetic diagnosis and improve guidance for care and family planning.

How similar studies have performed: Related DDD projects in Europe and elsewhere have raised diagnostic rates using genetic and computational methods, but applying combined CNV, methylation, and AI approaches to African data is relatively new.

Where this research is happening

Parktown, South Africa

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.